Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease

Journal of Crohn's & colitis

Volumn 9, Issue 10, 2015, Pages 899-906

  Busquets, David ^a   Mas de Xaxars, Teresa ^a   López Siles, Mireia ^a   Martínez Medina, Margarita ^a   Bahí, Anna ^a   Sàbat, Miriam ^b   Louvriex, René ^a   Miquel Cusachs, Josep O riol ^b   Garcia Gil, Jesus L ^b   Aldeguer, Xavier ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Adalimumab; ; anti TNF agents; Crohn s disease; gut microbiota

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT;

ADULT; CASE CONTROL STUDY; CROHN DISEASE; DRUG EFFECTS; FEMALE; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; MALE; MICROBIOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; YOUNG ADULT;

ADALIMUMAB; ADULT; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); YOUNG ADULT;

EID: 84981240884     PISSN: None     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv119     Document Type: Article

References (0)